Clinical Trials Directory

Trials / Completed

CompletedNCT04751175

Management of Pain in Lumbar Arthrodesis

Ketamine and Dexametasone in the Management of Pain in Lumbar Arthrodesis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dexamethasone administration perioperatively in patients undergoing lumbar arthrodesis.

Detailed description

The need to carry out this study is to evaluate the analgesic effects after the administration of ketamine and dexamethasone intravenously perioperatively in patients undergoing lumbar arthrodesis and, likewise, study the incidence of pain and protocolize perioperative analgesia.

Conditions

Interventions

TypeNameDescription
DRUGKetamineKetamine, being a non-competitive antagonist of NMDA receptors, could represent a good option as an opioid treatment enhancer for acute postoperative pain and avoid chronic pain, by reducing the '' wind-up '' phenomenon of central sensitization
DRUGDexamethasoneA meta-analysis published in September 2011 affirms that the administration of dexamethasone at a dose of 0.1 mg / kg is an effective complement to multimodal analgesia strategies to reduce postoperative pain and opioid consumption after surgery. Preoperative administration of the drug produces a more consistent analgesic effect than intraoperative administration
DRUGPhysiologic salineplacebo

Timeline

Start date
2013-07-04
Primary completion
2025-07-31
Completion
2025-12-31
First posted
2021-02-12
Last updated
2026-03-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04751175. Inclusion in this directory is not an endorsement.